Safety considerations and side effects Honest discussion of risks separates useful information from marketing copy
Retatrutide is a more recently developed investigational compound a triple agonist targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
Compounded tirzepatide formulations, including those with B12, present distinct safety considerations that differ from FDA-approved products
During your consultation, our team will discuss your diet, lifestyle, current medications, and health conditions before creating a customized nutritional IV drip to fit your goals and help you feel better
Apovian suggests talking to parents "in the same way you would if you're worried your mother has cancer there's no real difference" when chronic obesity, diabetes or weight-related heart issues are the issue, she says
doi:10.1093/humupd/dmy009